Ayurvedic clinical profile of COVID-19 - A preliminary report - PubMed (original) (raw)
Ayurvedic clinical profile of COVID-19 - A preliminary report
Rammanohar Puthiyedath et al. J Ayurveda Integr Med. 2022 Jan-Mar.
Abstract
Background: Ayurvedic clinical profiling of COVID-19 is a pre-requisite to develop standalone and integrative treatment approaches. At present, Ayurvedic clinicians do not have access to COVID-19 patients in clinical settings. In these circumstances, a preliminary clinical profiling of COVID-19 based on review of modern medical and classical Ayurvedic literature with inputs from Allopathic clinicians treating COVID-19 patients assumes significance.
Objectives: This paper aims to develop an Ayurvedic clinical profile of COVID-19 by literature review supported by analysis of clinical data of a cohort of COVID-19 patients.
Methods: The typical clinical presentation of COVID-19 was categorized based on a cluster of symptoms with reference to "Interim Clinical Guidance for Management of Patients with confirmed corona virus disease (COVID-19)" released by the US CDC. As the clinical presentation is found to vary widely, research papers reporting clinical symptoms of patient samples from different parts of the world were also reviewed to identify outliers and atypical presentations. Case records of fourteen COVID-19 patients treated at Medanta Hospital, Gurgaon were analyzed to compare symptomatology with data obtained from published literature. Further, a careful correlation was done with the data collected from selected Ayurvedic classical texts and expert views of clinical practitioners to arrive at a preliminary Ayurvedic clinical profile of COVID-19.
Results: COVID-19 can be understood from the Ayurvedic perspective as vātakapha dominant sannipātajvara of āgantu origin with pittānubandha. The asymptomatic, presymptomatic, mild, moderate, severe and critical stages of COVID-19 with varying clinical presentations have been analysed on the basis of nidāna, doṣa, dūṣya, nidānapañcaka and ṣaṭkriyākāla to present a preliminary clinical profile of the disease.
Conclusion: In this paper, we have demonstrated that a preliminary clinical profiling of COVID-19 from the Ayurvedic perspective is possible through literature review supported by discussions with Allopathic clinicians as well as examination of patient case records. The provisional diagnosis proposed can be further developed with continued review of literature, wider cooperation and teamwork with Allopathic physicians and access to clinical data as well as direct clinical assessment of COVID-19 patients.
Keywords: Ayurveda; COVID-19; Clinical profile; Integrative protocol; Pathogenesis.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest Dr. Unnikrishnan PM, listed as the third author, is on the Editorial Board of the Journal, but he was not involved in peer review process and editorial decisions related to this paper.
Figures
Fig. 1
Clinical course of COVID-19.
Similar articles
- Comparative retrospective open-label study of ayurvedic medicines and their combination with allopathic drugs on asymptomatic and mildly-symptomatic COVID-19 patients.
Balkrishna A, Bhatt AB, Singh P, Haldar S, Varshney A. Balkrishna A, et al. J Herb Med. 2021 Oct;29:100472. doi: 10.1016/j.hermed.2021.100472. Epub 2021 May 21. J Herb Med. 2021. PMID: 34055580 Free PMC article. - The efficacy of Ayurvedic treatment for rheumatoid arthritis: Cross-sectional experiential profile of a longitudinal study.
Krishna KP. Krishna KP. Int J Ayurveda Res. 2011 Jan;2(1):8-13. doi: 10.4103/0974-7788.83177. Int J Ayurveda Res. 2011. PMID: 21897637 Free PMC article. - The use of integrative therapy based on Yoga and Ayurveda in the treatment of a high-risk case of COVID-19/SARS-CoV-2 with multiple comorbidities: a case report.
Mishra A, Bentur SA, Thakral S, Garg R, Duggal B. Mishra A, et al. J Med Case Rep. 2021 Feb 24;15(1):95. doi: 10.1186/s13256-020-02624-1. J Med Case Rep. 2021. PMID: 33627186 Free PMC article. - The effectiveness of ayurvedic oil-based nasal instillation (Nasya) medicines in the treatment of facial paralysis (Ardita): a systematic review.
Vivera MJ, Gomersall JS. Vivera MJ, et al. JBI Database System Rev Implement Rep. 2016 Apr;14(4):198-228. doi: 10.11124/JBISRIR-2016-2402. JBI Database System Rev Implement Rep. 2016. PMID: 27532316 Review. - Ayurveda and Allopathic Therapeutic Strategies in Coronavirus Pandemic Treatment 2020.
Talwar S, Sood S, Kumar J, Chauhan R, Sharma M, Tuli HS. Talwar S, et al. Curr Pharmacol Rep. 2020;6(6):354-363. doi: 10.1007/s40495-020-00245-2. Epub 2020 Oct 22. Curr Pharmacol Rep. 2020. PMID: 33106765 Free PMC article. Review.
Cited by
- COVID-19 patient with B cell lymphoma co-morbidity managed with co-administration of ayurvedic formulation.
Dilip Pandkar P, Deshmukh SR, Sachdeva V. Dilip Pandkar P, et al. J Ayurveda Integr Med. 2022 Jul-Sep;13(3):100632. doi: 10.1016/j.jaim.2022.100632. Epub 2022 Aug 12. J Ayurveda Integr Med. 2022. PMID: 35975131 Free PMC article. - Structure-based docking, pharmacokinetic evaluation, and molecular dynamics-guided evaluation of traditional formulation against SARS-CoV-2 spike protein receptor bind domain and ACE2 receptor complex.
Kumar BH, Manandhar S, Mehta CH, Nayak UY, Pai KSR. Kumar BH, et al. Chem Zvesti. 2022;76(2):1063-1083. doi: 10.1007/s11696-021-01917-z. Epub 2021 Oct 18. Chem Zvesti. 2022. PMID: 34690412 Free PMC article. - Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19.
Singh R, Goel S, Bourgeade P, Aleya L, Tewari D. Singh R, et al. Environ Sci Pollut Res Int. 2021 Oct;28(40):55925-55951. doi: 10.1007/s11356-021-16280-5. Epub 2021 Sep 7. Environ Sci Pollut Res Int. 2021. PMID: 34491498 Free PMC article. Review. - Ayurveda co-interventions have supported complete recovery in severe COVID-19 infection with a chest severity score 18/25: A case report.
Rastogi S. Rastogi S. J Ayurveda Integr Med. 2022 Apr-Jun;13(2):100417. doi: 10.1016/j.jaim.2021.02.008. Epub 2021 Mar 12. J Ayurveda Integr Med. 2022. PMID: 33727768 Free PMC article. - Modulation of neutrophil (dys)function by Ayurvedic herbs and its potential influence on SARS-CoV-2 infection.
Joshi MB, Kamath A, Nair AS, Yedehali Thimmappa P, Sriranjini SJ, Gangadharan GG, Satyamoorthy K. Joshi MB, et al. J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100424. doi: 10.1016/j.jaim.2021.03.006. Epub 2021 Mar 16. J Ayurveda Integr Med. 2022. PMID: 33746457 Free PMC article. Review.
References
- Johns Hopkins University . CSSE) at Johns Hopkins University; 2020. Coronavirus COVID-19 global cases by the center for systems science and engineering.https://coronavirus.jhu.edu/map.html Available at:
- Frayer L., Pathak S. 2020. India's doctors worry the country is unprepared for a coronavirus surge. npr.https://www.npr.org/sections/coronavirus-live-updates/2020/03/26/8218951... Available at:
- Mampatta S., Das S. Business Standard; 2020. Doctors to hand wash: why India isn't ready for coronavirus crisis.https://www.business-standard.com/article/current-affairs/coronavirus-in... Available at:
- World Health Organisation . 2020. COVID-19 strategic preparedness and response plan operational planning guidelines to support country preparedness and response.
- National Health Policy . Government of India; 2017. https://www.nhp.gov.in/nhpfiles/national_health_policy_2017.pdf Available at:
LinkOut - more resources
Full Text Sources
Research Materials